Altria Group (MO)
(Delayed Data from NYSE)
$50.10 USD
+0.12 (0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $50.02 -0.08 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$50.10 USD
+0.12 (0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $50.02 -0.08 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Zacks News
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RHS)?
by Zacks Equity Research
Sector ETF report for RHS
Altria (MO) Q1 Earnings & Revenues Top Estimates, Pricing Aids
by Zacks Equity Research
Altria Group's (MO) first-quarter 2022 results reflect increased revenues and earnings. Pricing remains an upside, though shipment volumes appear soft.
Altria (MO) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 2.75% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Altria Group (MO) in Q1 Earnings?
by Zacks Equity Research
Altria Group's (MO) first-quarter results are likely to reflect gains from pricing and oral tobacco products, while cigarette volumes are likely to have been soft.
Altria (MO) Stock Moves -1.77%: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $55.53 in the latest trading session, marking a -1.77% move from the prior day.
Altria (MO) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $55.22, marking a +1.14% move from the previous day.
Post Holdings (POST) Provides Adjusted EBITDA View for FY22
by Zacks Equity Research
Post Holdings (POST) offers the adjusted EBITDA guidance for fiscal 2022, which takes into account the labor market and the input cost scenario and the latest avian influenza-related announcement.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $54.45 in the latest trading session, marking a +0.63% move from the prior day.
Coty (COTY) Up More Than 10% in 6 Months: More Room for Growth?
by Zacks Equity Research
Coty (COTY) has been gaining from its six core priorities and prudent alliances. The company's solid products and brands have been aiding, while cost inflation and supply-chain woes hurt.
The J.M. Smucker (SJM) Troubled by High Costs: Pricing Aids
by Zacks Equity Research
The J.M. Smucker Company (SJM) is battling cost-related challenges and supply-chain hurdles. However, revival in the Away from Home division and pricing actions bode well.
Sysco (SYY) Benefits From Recipe for Growth: Cost Woes Stay
by Zacks Equity Research
Sysco Corporation (SYY) is gaining on its Recipe for Growth plan, which involves five strategic priorities. However, high labor and transport costs pose threat to margins.
Medifast (MED) Troubled by High SG&A Costs, Gross Margin Woes
by Zacks Equity Research
Medifast (MED) has been seeing high SG&A expenses for a while now, mainly due to higher OPTAVIA commission costs. The company's gross margin has also been under pressure.
Philip Morris (PM) Benefits From Pricing Power & Focus on RRPs
by Zacks Equity Research
Philip Morris (PM) has been benefiting from its strong pricing power. Additionally, its focus on moving toward a majority smoke-free company bodes well.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $52.72, moving +0.02% from the previous trading session.
Altria (MO) Gains on Strong Pricing & Oral Tobacco Products
by Zacks Equity Research
Altria Group (MO) has been benefiting from its strong pricing power. Additionally, a focus on oral tobacco products has been driving growth for the company.
Turning Point Brands (TPB) Stock Jumps 5.5%: Will It Continue to Soar?
by Zacks Equity Research
Turning Point Brands (TPB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $51.68, moving -0.67% from the previous trading session.
Should Principal Value ETF (PY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PY
Is Principal Value ETF (PY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PY
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $52.25, marking a +1.1% move from the previous day.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $51.54, moving +1.98% from the previous trading session.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $51.23 in the latest trading session, marking a +0.45% move from the prior day.